Nucleoside Phosphate

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 5349 Experts worldwide ranked by ideXlab platform

Adam Kraszewski - One of the best experts on this subject based on the ideXlab platform.

Stephen J Butler - One of the best experts on this subject based on the ideXlab platform.

  • a simple robust universal assay for real time enzyme monitoring by signalling changes in Nucleoside Phosphate anion concentration using a europium iii based anion receptor
    Chemical Science, 2019
    Co-Authors: Sarah H Hewitt, Romain Mailhot, Rozee Ali, Chloe R. Antonen, Charlotte A. Dodson, Stephen J Butler
    Abstract:

    Enzymes that consume and produce Nucleoside polyPhosphate (NPP) anions represent major targets in drug discovery. For example, protein kinases are one of the largest classes of drug targets in the fight against cancer. The accurate determination of enzyme kinetics and mechanisms is a critical aspect of drug discovery research. To increase confidence in the selection of lead drug compounds it is crucial that pharmaceutical researchers have robust, affordable assays to measure enzyme activity accurately. We present a simple, sensitive microplate assay for real-time monitoring of a range of pharmaceutically important enzyme reactions that generate NPP anions, including kinases and glycosyltransferases. Our assay utilises a single, stable europium(iii) complex that binds reversibly to NPP anions, signalling the dynamic changes in NPP product/substrate ratio during an enzyme reaction using time-resolved luminescence. This supramolecular approach to enzyme monitoring overcomes significant limitations in existing assays, obviating the need for expensive antibodies or equipment, chemically labelled substrates or products and isolation or purification steps. Our label and antibody-free method enables rapid and quantitative analysis of enzyme activities and inhibition, offering a potentially powerful tool for use in drug discovery, suitable for high-throughput screening of inhibitors and accurate measurements of enzyme kinetic parameters.

Sarah H Hewitt - One of the best experts on this subject based on the ideXlab platform.

  • Tuning the anion binding properties of lanthanide receptors to discriminate Nucleoside Phosphates in a sensing array
    2020
    Co-Authors: Sarah H Hewitt, Georgina Macey, Romain Mailhot, Mark Elsegood, Fernanda Duarte, Alan M Kenwright, Stephen Butler
    Abstract:

    The development of synthetic receptors for the selective binding and discrimination of anions in water requires an understanding of how anions interact with these synthetic receptors. Molecules designed to differentiate Nucleoside Phosphate anions (e.g. ATP, ADP, GTP, GDP, UDP) under physiological conditions could underpin exciting new sensing tools for biomedical research and drug discovery, but it is very challenging due to the similarities in anion structure, size and charge. We present a series of lanthanide-based anion receptors and establish key structural elements that impact on Nucleoside Phosphate anion binding and sensing. Structural evidence of anion binding using X-ray crystallographic and NMR data, supported by DFT calculations indicate the binding modes between the lanthanide complexes and certain phosphoanions, revealing a bidentate (α-, γ-) binding mode to ATP. We further use four of the receptors to allow discrimination of eight Nucleoside Phosphate anions in the first array-based assay using lanthanide complexes, taking advantage of the multiple emission bands and long emission lifetimes associated with luminescent lanthanide complexes.

  • a simple robust universal assay for real time enzyme monitoring by signalling changes in Nucleoside Phosphate anion concentration using a europium iii based anion receptor
    Chemical Science, 2019
    Co-Authors: Sarah H Hewitt, Romain Mailhot, Rozee Ali, Chloe R. Antonen, Charlotte A. Dodson, Stephen J Butler
    Abstract:

    Enzymes that consume and produce Nucleoside polyPhosphate (NPP) anions represent major targets in drug discovery. For example, protein kinases are one of the largest classes of drug targets in the fight against cancer. The accurate determination of enzyme kinetics and mechanisms is a critical aspect of drug discovery research. To increase confidence in the selection of lead drug compounds it is crucial that pharmaceutical researchers have robust, affordable assays to measure enzyme activity accurately. We present a simple, sensitive microplate assay for real-time monitoring of a range of pharmaceutically important enzyme reactions that generate NPP anions, including kinases and glycosyltransferases. Our assay utilises a single, stable europium(iii) complex that binds reversibly to NPP anions, signalling the dynamic changes in NPP product/substrate ratio during an enzyme reaction using time-resolved luminescence. This supramolecular approach to enzyme monitoring overcomes significant limitations in existing assays, obviating the need for expensive antibodies or equipment, chemically labelled substrates or products and isolation or purification steps. Our label and antibody-free method enables rapid and quantitative analysis of enzyme activities and inhibition, offering a potentially powerful tool for use in drug discovery, suitable for high-throughput screening of inhibitors and accurate measurements of enzyme kinetic parameters.

Jacek Stawinski - One of the best experts on this subject based on the ideXlab platform.

Romain Mailhot - One of the best experts on this subject based on the ideXlab platform.

  • Tuning the anion binding properties of lanthanide receptors to discriminate Nucleoside Phosphates in a sensing array
    2020
    Co-Authors: Sarah H Hewitt, Georgina Macey, Romain Mailhot, Mark Elsegood, Fernanda Duarte, Alan M Kenwright, Stephen Butler
    Abstract:

    The development of synthetic receptors for the selective binding and discrimination of anions in water requires an understanding of how anions interact with these synthetic receptors. Molecules designed to differentiate Nucleoside Phosphate anions (e.g. ATP, ADP, GTP, GDP, UDP) under physiological conditions could underpin exciting new sensing tools for biomedical research and drug discovery, but it is very challenging due to the similarities in anion structure, size and charge. We present a series of lanthanide-based anion receptors and establish key structural elements that impact on Nucleoside Phosphate anion binding and sensing. Structural evidence of anion binding using X-ray crystallographic and NMR data, supported by DFT calculations indicate the binding modes between the lanthanide complexes and certain phosphoanions, revealing a bidentate (α-, γ-) binding mode to ATP. We further use four of the receptors to allow discrimination of eight Nucleoside Phosphate anions in the first array-based assay using lanthanide complexes, taking advantage of the multiple emission bands and long emission lifetimes associated with luminescent lanthanide complexes.

  • a simple robust universal assay for real time enzyme monitoring by signalling changes in Nucleoside Phosphate anion concentration using a europium iii based anion receptor
    Chemical Science, 2019
    Co-Authors: Sarah H Hewitt, Romain Mailhot, Rozee Ali, Chloe R. Antonen, Charlotte A. Dodson, Stephen J Butler
    Abstract:

    Enzymes that consume and produce Nucleoside polyPhosphate (NPP) anions represent major targets in drug discovery. For example, protein kinases are one of the largest classes of drug targets in the fight against cancer. The accurate determination of enzyme kinetics and mechanisms is a critical aspect of drug discovery research. To increase confidence in the selection of lead drug compounds it is crucial that pharmaceutical researchers have robust, affordable assays to measure enzyme activity accurately. We present a simple, sensitive microplate assay for real-time monitoring of a range of pharmaceutically important enzyme reactions that generate NPP anions, including kinases and glycosyltransferases. Our assay utilises a single, stable europium(iii) complex that binds reversibly to NPP anions, signalling the dynamic changes in NPP product/substrate ratio during an enzyme reaction using time-resolved luminescence. This supramolecular approach to enzyme monitoring overcomes significant limitations in existing assays, obviating the need for expensive antibodies or equipment, chemically labelled substrates or products and isolation or purification steps. Our label and antibody-free method enables rapid and quantitative analysis of enzyme activities and inhibition, offering a potentially powerful tool for use in drug discovery, suitable for high-throughput screening of inhibitors and accurate measurements of enzyme kinetic parameters.

  • A simple, robust, universal assay for real-time enzyme monitoring by signalling changes in Nucleoside Phosphate anion concentration using a europium(III)-based anion receptor
    2019
    Co-Authors: Sarah Hewitt, Romain Mailhot, Rozee Ali, Chloe R. Antonen, Charlotte A. Dodson, Stephen Butler
    Abstract:

    © 2019 The Royal Society of Chemistry. Enzymes that consume and produce Nucleoside polyPhosphate (NPP) anions represent major targets in drug discovery. For example, protein kinases are one of the largest classes of drug targets in the fight against cancer. The accurate determination of enzyme kinetics and mechanisms is a critical aspect of drug discovery research. To increase confidence in the selection of lead drug compounds it is crucial that pharmaceutical researchers have robust, affordable assays to measure enzyme activity accurately. We present a simple, sensitive microplate assay for real-time monitoring of a range of pharmaceutically important enzyme reactions that generate NPP anions, including kinases and glycosyltransferases. Our assay utilises a single, stable europium(iii) complex that binds reversibly to NPP anions, signalling the dynamic changes in NPP product/substrate ratio during an enzyme reaction using time-resolved luminescence. This supramolecular approach to enzyme monitoring overcomes significant limitations in existing assays, obviating the need for expensive antibodies or equipment, chemically labelled substrates or products and isolation or purification steps. Our label and antibody-free method enables rapid and quantitative analysis of enzyme activities and inhibition, offering a potentially powerful tool for use in drug discovery, suitable for high-throughput screening of inhibitors and accurate measurements of enzyme kinetic parameters